Psychstocks announced Revive Therapeutics (CSE: RVV) on October 21st as its #1 favorite psilocybin biotechnology stock suggestion at a price of $0.245 per share! RVV rallied by 30.95% today to hit a new all-time high of $0.55 per share for a gain of 124.49% from our official Psychstocks suggestion price!
Psychstocks announced Numinus Wellness (TSXV: NUMI) on August 6th as its #1 favorite psychedelic pick for the rest of 2020 at a price of $0.27 per share. NUMI hit a new record high today of $1.49 per share for a gain of 451.85% from our official Psychstocks suggestion price!
Psychstocks founder Gerard Adams considers RVV and NUMI to be the two highest quality small-cap stocks in the psychedelic space and their incredibly strong performance is proving Gerard right!
Past performance is not an indicator of future returns. Psychstocks is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The parent company of Psychstocks has been compensated by RVV USD$30,000 cash for a six-month marketing contract. The parent company of Psychstocks has been compensated by NUMI USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.